Science & Technology
Commercialization Readiness of Immune Mediator Based Blood Tests that Inform Concurrent and Future Clinical Disease Activity in Systemic Lupus Erythematosus (SLE)
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1SB1AI184309-01
Award Ceiling
$1.8M
Award Floor
$1.8M
Close Date
May 31, 2027
442 days leftTotal Funding
$1.8M
Expected Awards
1
Posted Date
Jun 25, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1SB1AI184309-01
Description
SBIR Phase Phase II award: "Commercialization Readiness of Immune Mediator Based Blood Tests that Inform Concurrent and Future Clinical Disease Activity in Systemic Lupus Erythematosus (SLE)" awarded to PROGENTEC DIAGNOSTICS INC in OKLAHOMA CITY, Oklahoma. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,790,280. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.